Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-22-070591
Filing Date
2022-03-09
Accepted
2022-03-09 16:22:56
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A d280243ddefa14a.htm DEFA14A 21498
2 GRAPHIC g280243g70d20.jpg GRAPHIC 68095
  Complete submission text file 0001193125-22-070591.txt   116748
Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: DEFA14A | Act: 34 | File No.: 001-38042 | Film No.: 22725651
SIC: 2834 Pharmaceutical Preparations